
2005 No. 3324
MEDICINES
The Medicines for Human Use (Prescribing) (Miscellaneous Amendments) (No. 2) Order 2005
Made 2nd December 2005
Laid before Parliament 9th December 2005
Coming into force 6th January 2006

The Secretary of State for Health and the Department of Health, Social Services and Public Safety, acting jointly, make the following Regulations in the exercise of the powers conferred upon them by sections 57(1) and (2), 58(1), (4), (4A), and (5) and 129(4) of the Medicines Act 1968, or, as the case may be, the powers conferred by those provisions and now vested in them.

In accordance with section 129(6) of that Act, they have consulted such organisations as appear to them to be representative of interests likely to be substantially affected by this Order. In accordance with sections 58(6) and 129(7) of that Act, they have consulted and taken into account the advice of the Committee on Safety of Medicines.
Citation, commencement and interpretation
1 

(1) This Order may be cited as the Medicines for Human Use (Prescribing) (Miscellaneous Amendments) (No. 2) Order 2005 and shall come into force on 6th January 2006.
(2) In this Order—
 “the POM Order” means the Prescription Only Medicines (Human Use) Order 1997;
 “the Pharmacy and General Sale Order” means the Medicines (Pharmacy and General Sale—Exemption) Order 1980.
Amendment of Schedule 3A to the POM Order
2 
In the table in Schedule 3A to the POM Order (substances which may be prescribed, administered or directed for administration by extended formulary nurse prescribers and conditions for such prescription or administration), in column 1, insert, at the appropriate place in the alphabetical order of the entries as they appear in that column, the entries set out in column 1 below, and in column 2, insert, against those entries, the corresponding entries in column 2 below—

Column 1 Column 2
Buprenorphine Transdermal administration in palliative care
Chlordiazepoxide hydrochloride Oral
Diamorphine hydrochloride Oral and parenteral
Fentanyl Transdermal administration in palliative care
Morphine sulphate Oral, parenteral and rectal
Morphine hydrochloride Rectal
Oxycodone hydrochloride Oral and parenteral administration in palliative care
Amendment of Schedule 5 to the POM Order
3 
In the table in Part I of Schedule 5 to the POM Order (exemption from restrictions on sale or supply), in paragraph 6A, column 2, insert, at the appropriate place in the alphabetical order of the entries as they appear in that column, “Pilocarpine nitrate”.
Amendment of Schedule 1 to the Pharmacy and General Sale Order
4 
In the table in Part I of Schedule 1 to the Pharmacy and General Sale Order, in paragraph 2A, in column 2, insert, at the appropriate place in the alphabetical order of the entries as they appear in that paragraph, “Pilocarpine nitrate”.
Signed by authority of the Secretary of State for Health
Jane Kennedy
Minister of State,
Department of Health
27th November 2005Sealed with the Official Seal of the Department of Health, Social Services and Public Safety
Andrew McCormick
Permanent Secretary,
Department of Health, Social Services and Public Safety
2nd December 2005